SEC Form 4 · accession 0001179110-15-003161
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Chase
Officer — EVP, Chief Financial Officer
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par valueF1,F2 | Feb 19, 2015 | A | 56,040 | $0.00 | A | 236,519 | D | |
| Common stock, $0.01 par valueF3 | holding | — | — | — | 501 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F4 | $58.88 | Feb 19, 2015 | A | 110,770 | A | Feb 19, 2016 | Feb 18, 2025 | Common stock | 110,770 | 110,770 | D |
Explanation of responses
- F1These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- F2The amount of securities beneficially owned by the reporting person includes an additional 411 shares of AbbVie stock.
- F3The reporting person disclaims beneficial ownership of all securities held by his spouse.
- F4Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 36,924 on 02/19/2016, 36,923 on 02/19/2017, and 36,923 on 02/18/2018